Thomas H Hsu, MD
Urology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hsu’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A78861 · Current
Licensed to practise in California · since 2002 · expires 2028-04-30 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,922
Medicare paid this office $1,922 for 12 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
12 Original Medicare patients in 2024. Average age 62 · Health risk score 2.36. Sicker patients than 9 in 10 peers; the typical urology clinician is at 1.36.
The office billed $7,991, Medicare allowed $2,637 and paid $1,922; for 21 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 12 | 21 | 62 | 2.36 | $7,991 | $1,922 |
| 2023 | 11 | 13 | 71 | 1.11 | $8,999 | $742 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$24,868
Pharmacies billed $24,868 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (12 of 635) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
618 generic and fewer than 11 brand-name prescriptions · $24,868 in drug cost · 99 antibiotic prescriptions to 78 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 14 | $11,450 | $818 |
| Tamsulosin | 187 | $3,380 | $18 |
| Finasteride | 182 | $2,813 | $15 |
| Terazosin | 18 | $1,035 | $58 |
| Oxybutynin Chloride | 49 | $954 | $19 |
See all 11 drugs
| Myrbetriq | 14 | $11,450 | $818 |
| Tamsulosin | 187 | $3,380 | $18 |
| Finasteride | 182 | $2,813 | $15 |
| Terazosin | 18 | $1,035 | $58 |
| Oxybutynin Chloride | 49 | $954 | $19 |
| Trospium Chloride | 15 | $937 | $62 |
| Ciprofloxacin | 39 | $292 | $7 |
| Cephalexin | 24 | $287 | $12 |
| Oxybutynin Chloride Er | 12 | $173 | $14 |
| Sulfamethoxazole-Trimethoprim | 22 | $137 | $6 |
| Oxycodone | 11 | $72 | $7 |
Year by year
| 2024 | 635 | 266 | 2% (12) | None | $24,868 |
| 2023 | 622 | 272 | 3% (18) | None | $17,577 |
| 2022 | 658 | 301 | 4% (29) | None | $27,739 |
| 2021 | 702 | 310 | 2% (11) | 3% | $29,425 |
| 2020 | 509 | 234 | 2% (11) | None | $15,190 |
| 2019 | 460 | 247 | None | 3% | $17,808 |
| 2018 | 495 | 227 | 4% (19) | 3% | $20,170 |
| 2017 | 402 | 180 | 6% (22) | None | $16,486 |
| 2016 | 365 | 172 | None | 5% | $19,143 |
| 2015 | 373 | 170 | 6% (24) | None | $21,815 |
| 2014 | 493 | 160 | 6% (29) | 9% | $27,675 |
| 2013 | 565 | 164 | 6% (32) | None | $34,916 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Finasteride | 183 | $2,787 | $15 |
| Tamsulosin | 147 | $2,692 | $18 |
| Trospium Chloride | 18 | $1,276 | $71 |
| Terazosin | 14 | $975 | $70 |
| Oxybutynin Chloride | 42 | $793 | $19 |
| Amoxicillin-Clavulanate Potass | 24 | $456 | $19 |
| Ciprofloxacin | 58 | $435 | $8 |
| Cephalexin | 19 | $211 | $11 |
| Oxybutynin Chloride Er | 11 | $187 | $17 |
| Sulfamethoxazole-Trimethoprim | 17 | $113 | $7 |
| Oxycodone | 15 | $94 | $6 |
2022: 13 drugs
| Lantus | 11 | $3,000 | $273 |
| Tamsulosin | 120 | $2,537 | $21 |
| Finasteride | 155 | $2,465 | $16 |
| Terazosin | 24 | $1,692 | $70 |
| Oxybutynin Chloride | 50 | $1,056 | $21 |
| Trospium Chloride | 11 | $801 | $73 |
| Ciprofloxacin | 57 | $385 | $7 |
| Amoxicillin-Clavulanate Potass | 18 | $285 | $16 |
| Losartan | 15 | $261 | $17 |
| Cephalexin | 19 | $218 | $11 |
| Hydrocodone-Acetaminophen | 28 | $197 | $7 |
| Sulfamethoxazole-Trimethoprim | 23 | $154 | $7 |
| Simvastatin | 12 | $85 | $7 |
2021: 12 drugs
| Tamsulosin | 146 | $3,004 | $21 |
| Finasteride | 127 | $1,978 | $16 |
| Terazosin | 26 | $1,638 | $63 |
| Oxybutynin Chloride | 43 | $1,476 | $34 |
| Amoxicillin-Clavulanate Potass | 19 | $304 | $16 |
| Cephalexin | 24 | $287 | $12 |
| Ciprofloxacin | 43 | $275 | $6 |
| Losartan | 19 | $240 | $13 |
| Amlodipine Besylate | 11 | $214 | $19 |
| Omeprazole | 13 | $208 | $16 |
| Sulfamethoxazole-Trimethoprim | 23 | $158 | $7 |
| Metformin | 12 | $129 | $11 |
2020: 8 drugs
| Tamsulosin | 138 | $3,065 | $22 |
| Finasteride | 95 | $2,277 | $24 |
| Oxybutynin Chloride | 35 | $1,242 | $35 |
| Terazosin | 24 | $899 | $37 |
| Ciprofloxacin | 41 | $323 | $8 |
| Amoxicillin-Clavulanate Potass | 17 | $298 | $18 |
| Cephalexin | 14 | $165 | $12 |
| Hydrocodone-Acetaminophen | 11 | $87 | $8 |
2019: 7 drugs
| Oxybutynin Chloride | 38 | $3,547 | $93 |
| Tamsulosin | 119 | $3,157 | $27 |
| Finasteride | 92 | $2,236 | $24 |
| Terazosin | 21 | $812 | $39 |
| Ciprofloxacin | 60 | $439 | $7 |
| Cephalexin | 32 | $370 | $12 |
| Sulfamethoxazole-Trimethoprim | 11 | $78 | $7 |
2018: 9 drugs
| Tamsulosin | 136 | $4,132 | $30 |
| Oxybutynin Chloride | 45 | $3,845 | $85 |
| Trospium Chloride | 17 | $2,790 | $164 |
| Finasteride | 92 | $2,238 | $24 |
| Cephalexin | 38 | $565 | $15 |
| Ciprofloxacin | 59 | $445 | $8 |
| Terazosin | 14 | $386 | $28 |
| Sulfamethoxazole-Trimethoprim | 17 | $159 | $9 |
| Hydrocodone-Acetaminophen | 13 | $110 | $8 |
2017: 7 drugs
| Oxybutynin Chloride | 44 | $4,280 | $97 |
| Tamsulosin | 105 | $3,975 | $38 |
| Finasteride | 55 | $1,448 | $26 |
| Ciprofloxacin | 59 | $506 | $9 |
| Cephalexin | 37 | $502 | $14 |
| Terazosin | 19 | $257 | $14 |
| Hydrocodone-Acetaminophen | 17 | $215 | $13 |
2016: 7 drugs
| Tamsulosin | 107 | $7,329 | $68 |
| Oxybutynin Chloride | 28 | $2,590 | $92 |
| Finasteride | 62 | $2,099 | $34 |
| Cephalexin | 27 | $476 | $18 |
| Ciprofloxacin | 42 | $378 | $9 |
| Terazosin | 20 | $280 | $14 |
| Sulfamethoxazole-Trimethoprim | 13 | $208 | $16 |
2015: 7 drugs
| Finasteride | 70 | $6,880 | $98 |
| Tamsulosin | 88 | $5,568 | $63 |
| Oxybutynin Chloride | 37 | $3,549 | $96 |
| Terazosin | 42 | $556 | $13 |
| Ciprofloxacin | 50 | $439 | $9 |
| Cephalexin | 19 | $326 | $17 |
| Hydrocodone-Acetaminophen | 11 | $190 | $17 |
2014: 8 drugs
| Finasteride | 67 | $7,047 | $105 |
| Tamsulosin | 62 | $2,776 | $45 |
| Oxybutynin Chloride | 27 | $1,786 | $66 |
| Terazosin | 35 | $455 | $13 |
| Ciprofloxacin | 48 | $352 | $7 |
| Sulfamethoxazole-Trimethoprim | 19 | $255 | $13 |
| Hydrocodone-Acetaminophen | 23 | $223 | $10 |
| Meloxicam | 14 | $83 | $6 |
2013: 11 drugs
| Finasteride | 74 | $7,845 | $106 |
| Tamsulosin | 69 | $2,781 | $40 |
| Oxybutynin Chloride | 36 | $2,024 | $56 |
| Clopidogrel | 11 | $1,600 | $145 |
| Ciprofloxacin | 71 | $513 | $7 |
| Terazosin | 31 | $415 | $13 |
| Sulfamethoxazole-Trimethoprim | 14 | $289 | $21 |
| Hydrocodone-Acetaminophen | 27 | $259 | $10 |
| Cephalexin | 13 | $241 | $19 |
| Meloxicam | 26 | $153 | $6 |
| Benazepril | 14 | $78 | $6 |
Money from drug and device companies
$125 in 2024
| 2024 | 1 | 1 | None | $125 |
| 2022 | 1 | 1 | $40 | $40 |
| 2019 | 1 | 1 | None | $94 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | Vemlidy | $125 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2024-03-28 | Vemlidy | $125 |
See earlier years (2022, 2019)
2022: $40
| Medtronic | None | $40 | 1 payment
|
2019: $94
| Boehringer Ingelheim Pharmaceuticals | None | $94 | 1 payment
|
Professional record
- NPI
- 1851433833
- Licence
- CA A78861California A78861: Current · expires 2028-04-30
- Trained
- University of California, Geffen School of Medicine, 1995
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A788610
- Taxonomy
- Urology (208800000X)
- Mailing address
- 875 Blake Wilbur Dr, Stanford Cancer Center, Palo Alto, CA, 94304
- NPI first listed
- 2007-02-13
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.